UBS Group’s GRI Bio GRI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $19.9K | Buy |
15,455
+12,210
| +376% | +$15.8K | ﹤0.01% | 7135 |
|
2025
Q1 | $10.4K | Sell |
3,245
-2,182
| -40% | -$6.98K | ﹤0.01% | 7320 |
|
2024
Q4 | $76.4K | Buy |
5,427
+1,212
| +29% | +$17.1K | ﹤0.01% | 5824 |
|
2024
Q3 | $25.9K | Buy |
4,215
+3,158
| +299% | +$19.4K | ﹤0.01% | 6005 |
|
2024
Q2 | $34.5K | Buy |
1,057
+1,021
| +2,836% | +$33.3K | ﹤0.01% | 5826 |
|
2024
Q1 | $6.1K | Buy |
36
+34
| +1,700% | +$5.76K | ﹤0.01% | 6311 |
|
2023
Q4 | $922 | Buy |
+2
| New | +$922 | ﹤0.01% | 7258 |
|
2023
Q3 | – | Sell |
-1
| Closed | -$3.82K | – | 8443 |
|
2023
Q2 | $3.82K | Buy |
+1
| New | +$3.82K | ﹤0.01% | 6516 |
|
2023
Q1 | – | Hold |
0
| – | -$5.9K | – | 7725 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 7921 |
|
2022
Q2 | – | Hold |
0
| – | -$17K | – | 9427 |
|
2022
Q1 | – | Hold |
0
| – | -$17K | – | 6605 |
|
2021
Q4 | – | Hold |
0
| – | -$11K | – | 6945 |
|
2021
Q3 | – | Hold |
0
| – | -$4K | – | 6735 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 7557 |
|